| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/16/2003 | EP1301614A1 Codon-optimized papilloma virus sequences |
| 04/16/2003 | EP1301613A2 Modified virus having an altered tropism |
| 04/16/2003 | EP1301612A2 Method and composition for targeting an adenoviral vector |
| 04/16/2003 | EP1301611A2 Human rrp sequences and methods of use |
| 04/16/2003 | EP1301609A2 Zmaxig1-specific polynucleotides and methods of use |
| 04/16/2003 | EP1301606A1 Expression system |
| 04/16/2003 | EP1301605A2 Nk cells activating receptors and their therapeutic and diagnostic uses |
| 04/16/2003 | EP1301604A2 Substrates and assays for beta-secretase activity |
| 04/16/2003 | EP1301603A2 Production of a cellulose-like polysaccharide by pseudomonas fluorescens |
| 04/16/2003 | EP1301602A2 Fh-binding protein of streptococcus pneumoniae |
| 04/16/2003 | EP1301601A2 Complete nucleotide sequence of staphylococcus aureus ribosomal protein s16 gene and methods for the identification of antibacterial substances |
| 04/16/2003 | EP1301599A2 Olfactory g-protein coupled receptor |
| 04/16/2003 | EP1301598A2 Cell cycle proteins and mitosis-associated molecules |
| 04/16/2003 | EP1301597A2 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip) |
| 04/16/2003 | EP1301596A2 NEW SODIUM CHANNEL (rNAVI.5a) AND USE THEREOF |
| 04/16/2003 | EP1301595A2 G-protein coupled receptors |
| 04/16/2003 | EP1301594A2 Non-endogenous, consstitutively activated known g protein-coupled receptors |
| 04/16/2003 | EP1301585A2 Multimeric biopolymers as structural elements, sensors and actuators in microsystems |
| 04/16/2003 | EP1301541A2 Bifunctional molecules and vectors complexed therewith for targeted gene delivery |
| 04/16/2003 | EP1301540A2 Rgd (arg-gly-asp) coupled to neuropeptides |
| 04/16/2003 | EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 04/16/2003 | EP1301538A2 Artificial antibody polypeptides |
| 04/16/2003 | EP1301537A2 Peptides and their use in assays for cardiovascular disease |
| 04/16/2003 | EP1301536A2 Modulation of tetraspanin function |
| 04/16/2003 | EP1301535A2 G-protein coupled receptors |
| 04/16/2003 | EP1301534A2 Mutated pf-4, its fragments and mutated fusion peptides, their analogues, corresponding dna, cdna and mrna sequences and their use for inhibiting angiogenesis |
| 04/16/2003 | EP1301533A1 Tumour-associated antigen (b345), characterised by an amino acid sequence as in seq. id. no. 4 |
| 04/16/2003 | EP1301532A2 Plant cyclin-dependent kinase inhibitors |
| 04/16/2003 | EP1301531A2 Reagents and methods for identification of binding agents |
| 04/16/2003 | EP1301530A2 Multiple antigenic peptides immunogenic against streptococcus pneumoniae |
| 04/16/2003 | EP1301529A2 Novel nucleus export signal peptides (nes), fusion proteins containing the same, and the use thereof |
| 04/16/2003 | EP1301527A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 04/16/2003 | EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies |
| 04/16/2003 | EP1301473A2 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation |
| 04/16/2003 | EP1301238A1 Vaccines |
| 04/16/2003 | EP1301213A2 Multi-component biological transport systems |
| 04/16/2003 | EP1301202A2 Genetically-engineered mhc molecules |
| 04/16/2003 | EP1301195A2 Pharmaceutical use of fibulin-1 |
| 04/16/2003 | EP1301146A2 Artificial vascular grafts, and methods of producing and using same |
| 04/16/2003 | EP1301075A1 Modified serum albumin with reduced affinity for nickel and copper |
| 04/16/2003 | EP1200105A4 Modified factor viii |
| 04/16/2003 | EP1041997B1 Use of citrulline peptides derived from filaggrin for treating autoimmune diseases |
| 04/16/2003 | EP1025126B1 Purification of molecules |
| 04/16/2003 | EP0960209A4 Editing-based selectable plastid marker genes |
| 04/16/2003 | EP0921810B1 Reduction of the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity |
| 04/16/2003 | EP0918455B1 Use of galanin to repair nerve damage |
| 04/16/2003 | EP0877631B1 Conjugate of albumin and a xanthen dye for differentiating between diseased and healthy tissues |
| 04/16/2003 | EP0873404B1 Angiotensin converting enzyme inhibitors |
| 04/16/2003 | EP0868522B1 Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them |
| 04/16/2003 | EP0804481B1 Somatostatin derivatives and their radiolabelled products |
| 04/16/2003 | EP0789591B1 Methods for identifying individuals suffering from a cellular abnormality |
| 04/16/2003 | EP0769958B1 Inhibitors of leukocyte adhesion |
| 04/16/2003 | EP0750508B1 RETROPEPTIDES, ANTIBODIES THERETO, AND USES THEREOF FOR VACCINATION AND $i(IN VITRO) DIAGNOSIS |
| 04/16/2003 | EP0749443B1 Fk-506 cytosolic binding protein |
| 04/16/2003 | EP0746611B1 Method for increasing production of disulfide bonded recombinant proteins by (saccharomyces cerevisiae) |
| 04/16/2003 | EP0743861B1 Radiolabeled annexins |
| 04/16/2003 | EP0742796B1 Il-3 variant hematopoiesis fusion protein |
| 04/16/2003 | EP0667896B1 Direct selection of cells by secretion product |
| 04/16/2003 | EP0648271B1 Adenovirus mediated transfer of genes to the gastrointestinal tract |
| 04/16/2003 | EP0648127B1 Type i surface antigens associated with staphylococcus epidermidis |
| 04/16/2003 | EP0642356B1 Antibodies to p-selectin and their uses |
| 04/16/2003 | EP0630265B1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION |
| 04/16/2003 | EP0605442B1 Recombinant antibodies for human therapy |
| 04/16/2003 | EP0591462B1 Universal donor cells |
| 04/16/2003 | EP0570506B1 Bacillus thuringiensis isolates |
| 04/16/2003 | CN1411556A Synergistic activation of regulatory elements by Rel proteins and steroid receptor |
| 04/16/2003 | CN1411512A Chimeric immunogenic compositions and nucleir acids encoding them |
| 04/16/2003 | CN1411511A Monocotyledonous plant genes and uses thereof |
| 04/16/2003 | CN1411510A Photosensitivity gene Hdl of plant and utilization thereof |
| 04/16/2003 | CN1411509A Process for producing Kiss-1 peptide |
| 04/16/2003 | CN1411507A Method of detecting sexual differentiation disruptor |
| 04/16/2003 | CN1411505A Membrane virus host range mutations and their uses as vaccine stroma |
| 04/16/2003 | CN1411470A Transgenic mice expressing fluorescent protein |
| 04/16/2003 | CN1411469A Preparing process of desensitization proteins and replacement proteins |
| 04/16/2003 | CN1411468A Attenuated microorganisms for treatment of infection |
| 04/16/2003 | CN1411467A Compounds and use thereof to modify transport across cell membranes |
| 04/16/2003 | CN1411448A Pyrazole derivatives which modulate human 5-serotonin receptors |
| 04/16/2003 | CN1411369A Biodegradable microparticles with novel erythropoietin stimulating protein |
| 04/16/2003 | CN1410539A Recombinant human nerve growth factor expressed using yeast secretion |
| 04/16/2003 | CN1410450A Fc fusion protein of human granulocyte colony stimulin with enhanced bioactivity |
| 04/16/2003 | CN1410449A Identification and function research of gene p28-II |
| 04/16/2003 | CN1410448A Terminal blocked pentahelicoprotein and its use |
| 04/16/2003 | CN1105779C Process for preparation of factor IX from biological sources |
| 04/16/2003 | CN1105776C Method for controlling metallophosphate precipitation in high cell density fermentations |
| 04/16/2003 | CN1105727C Process for preparing recombined human serum albumin |
| 04/16/2003 | CN1105726C Human calcitonin analogue |
| 04/16/2003 | CN1105725C Modulators for functions of FAS/APO1 receptors |
| 04/16/2003 | CN1105576C Insulin analog formulation |
| 04/16/2003 | CN1105575C Lyophilized stem celi factor formulations |
| 04/16/2003 | CN1105574C Therapeutic uses of bactericidal/permeability increasing protein products |
| 04/15/2003 | US6548744 Reduction of bowman-birk protease inhibitor levels in plants |
| 04/15/2003 | US6548742 Isolated Raspberry Bushy Dwarf Virus (RBDV) nucleic acid sequences which encode RBDV coat and movement proteins or polypeptides and mutant or modified forms thereof; vectors, transgenic plants resistant to infection by RBDV |
| 04/15/2003 | US6548740 Introduction of exogenous nucleotide sequences into a genome by microinjection of infectious retrovirus into the perivitelline space of the egg; making a bovine embryo; use to confer disease resistance, for example |
| 04/15/2003 | US6548739 Method for activating peroxisome proliferator activated receptor-γ |
| 04/15/2003 | US6548735 5'-flanking sequence such as beta-lactoglobulin and DNA coding for a serine protease such as alpha1-antitrypsin or a blood factor |
| 04/15/2003 | US6548655 Interleukin-4 receptors |
| 04/15/2003 | US6548654 DNA encoding mammalian CX3C chemokine genes |
| 04/15/2003 | US6548653 Erythropoietin analog-human serum albumin fusion |
| 04/15/2003 | US6548644 Site protected protein modification |
| 04/15/2003 | US6548642 Expression of synthetic genes designed from repetitive peptide sequences of hydroxyproline-rich glycoproteins |